Reducing reflux after sleeve gastrectomy using gastropexy

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the effectiveness of gastropexy in reducing gastroesophageal reflux symptoms in morbidly obese patients undergoing sleeve gastrectomy. Participants will be randomly assigned to receive either gastropexy or no gastropexy during their surgery. The study will assess both subjective reflux symptoms and objective evidence of reflux over a follow-up period of five years. By suturing the gastric remnant to the gastrocolic ligament, the researchers hypothesize that they can prevent the migration of the stomach and thus reduce reflux incidence.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients planned for bariatric surgery with primary LSG

Exclusion Criteria:

* Age below 18 yrs
* Use of ARM for other reasons than reflux
* Previous antireflux surgery
* Inability to comprehend and respon to patient related outcome (PRO) questionnaire

Where it's running

• Aleris Oslo
  Oslo, Norway Recruiting
• Volda sjukehus
  Volda, Norway Recruiting
• Voss sjukehus
  Voss, Norway Recruiting
• Helse Forde
  Førde, Norway Not yet recruiting

Study contacts

• Study coordinator: Villy Vage, MD PhD
• Email: villy.vage@helse-bergen.no
• Phone: 47 90863744

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• POEM vs Heller myotomy with Dor fundoplication for achalasia

  This trial tests POEM against laparoscopic Heller myotomy with Dor fundoplication to see which procedure better helps adults with achalasia.

  Recruiting Minia University · Minya, Minya Governorate · NCT07814027

• Hydrotalcite (Talcid) for relief of rebound acid symptoms after stopping long-term PPI therapy

  We are trying hydrotalcite (Talcid) to see if it relieves rebound acid symptoms in adults who have stopped long-term PPI treatment.

  Recruiting Bayer · Multiple Locations · NCT07291700

• Detecting Barrett's Esophagus in Patients Without GERD Symptoms

  This study is testing a new way to find Barrett's esophagus in people who don’t have GERD symptoms by using a simple capsule test instead of the usual endoscopy.

  Recruiting at 5 sites Case Comprehensive Cancer Center · Aurora, Colorado and 4 other locations · NCT06687603

• Transpyloric versus gastric feeding for premature infants with bronchopulmonary dysplasia

  This trial will see if feeding premature infants with bronchopulmonary dysplasia directly into the small intestine (transpyloric) versus into the stomach reduces reflux and episodes of low oxygen.

  Recruiting at 3 sites Children's Hospital of Philadelphia · Palo Alto, California and 3 other locations · NCT06534359

• Measuring mucosal impedance to diagnose gastroesophageal reflux disease

  This study is testing a new way to measure the lining of the esophagus to see if it can help diagnose gastroesophageal reflux disease (GERD) better in patients who haven't improved with standard medications.

  Recruiting Hospital de Clinicas José de San Martín · Buenos Aires · NCT06339801

• Cow's-milk-protein-free diet versus omeprazole for reflux in infants

  This test compares a cow's-milk-protein-free diet to the medicine omeprazole for infants under one year who have troublesome gastroesophageal reflux.

  Recruiting Phase 4 Odense University Hospital · Aabenraa, Region Syddanmark and 2 other locations · NCT06255886

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.